Meropenem Ligula Pharma 1000 mg prašak za otopinu za injekciju/infuziju
| Name | Meropenem Ligula Pharma 1000 mg prašak za otopinu za injekciju/infuziju |
|---|---|
| Marketing Authorisation Number | HR-H-432057427 |
| Active Substance | meropenem trihidrat |
| Composition | jedna bočica sadrži meropenem trihidrat što odgovara 1000 mg bezvodnog meropenema |
| Pharmaceutical Form | Prašak za otopinu za injekciju / infuziju |
| Manufacturer | Venus Pharma GmbH, Werne, Njemačka European Pharma Hub Kft., Gyal, Mađarska |
| Marketing Authorisation Holder | Ligula Pharma d.o.o., Iblerov trg 7, Zagreb, Hrvatska |
| Marketing Authorisation Date | 14.10.2026 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/26-02/02 |
| Registration Number | 381-12-01/171-26-04 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product subject to restricted medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | J01DH02 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |